Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


Cell Culture & Bioprocessing Congress

05 Nov 2012 - 06 Nov 2012 - London, UK



Bookmark and Share


175 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

50 presentations, case studies and panel discussions focused on the key issues in cell line optimisation, process development and biological production

4 interactive streams:
•    Cell line development x2
•    Upstream process development
•    Biological production

14 prescheduled one to one meetings, Q&A sessions and exhibition spaces creating a unique platform for business and scientific discussion

Oxford Global Conferences are proud to present our Cell Culture & Bioprocessing Congress, taking place on 5th & 6th November, 2012 at the CBI Conference Centre in London.

Experts predict that the cell culture sector will be worth over $6 billion by 2015. The growth of the biopharma industry as whole, combined with the increasingly wide reach of cell culture applications has secured a prominent role for cell culture and bioprocessing in the pharmaceutical industry of the future.
This event is designed to offer clear and informed insights into the trends and solutions most relevant to those working in the industry. The conference programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, creating an interactive platform for high-level scientific and business discussion.

On Day One, our panel of cell engineering experts will discuss vector design, genome engineering and high throughput technologies. Delegates will also hear from those working at the forefront of process innovation, in areas such as disposable reactors, next generation fermentation and process characterisation.

Day Two will feature presentations covering the critical opportunities in cell line optimisation including, miniaturised systems, 3D cell culture and bioinformatic analysis. Our highly esteemed speakers will also explore the key challenges in biological production; topics will include CMO relationship management, technology transfer and the role of single-use technology.

The Cell Culture & Bioprocessing Congress is part of the highly successful Oxford Global Proteins Series.



Further information
Scientific News
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
Study Finds Factors That May Influence Influenza Vaccine Effectiveness
Researchers at NIH have suggested that the long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Improving Flu Vaccine Effectiveness
NIH study finds factors that may influence influenza vaccine effectiveness.
BMS’s Opdivo Clinical Trial Shows Promise
Safety profile of the combination regimen from CheckMate -069 was consistent with previously reported studies and adverse events were managed using established safety algorithms.
CNS Inflammation: A Pathway and Possible Drug Target
Scientists have long known that the central nervous system (CNS) has a remarkable ability to limit excessive inflammation in the presence of antigens or injury, but how it works has been unclear.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!